Clinical Trial Update: Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell [Phase 1]

View source ↗

Summary

Phase 1 study updating on CAR-20/19-T cells in relapsed/refractory B-cell lymphomas; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Lymphoma
• Lymphoma B-cell
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• CAR-20/19-T cells

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, B-Cell | Phase 1 | Status: COMPLETED | Results posted: 2021-05-07